Back
Citius Pharmaceuticals Vs. Agilent Technologies Industry Stock Comparison
Sell
17
CTXR
Citius Pharmaceuticals
Last Price:
0.54
Seasonality Move:
-3.95%
Sell
46
A
Agilent Technologies
Last Price:
141.97
Seasonality Move:
5.78%
Sell
17
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy, Sell or Hold?
- The current Citius Pharmaceuticals [CTXR] share price is $0.55. The Score for CTXR is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- CTXR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Agilent Technologies (A)
is a Sell
Is Agilent Technologies a Buy, Sell or Hold?
- The current Agilent Technologies [A] share price is $141.95. The Score for A is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- A is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CTXR Stock Price Chart
What is Citius Pharmaceuticals's stock price today?
-
The Citius Pharmaceuticals share price today is $0.55
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.
A Stock Price Chart
What is Agilent Technologies's stock price today?
-
The Agilent Technologies share price today is $141.95
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and A is experiencing selling pressure, which indicates risk of future bearish movement.
CTXR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 43.59 | Sell |
| Chaikin Money Flow: | -108168 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.52 - 0.6) | Sell |
| Bollinger Bands (100): | (0.55 - 0.81) | Sell |
A Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 60.85 | Buy |
| Chaikin Money Flow: | -599580 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (137.88 - 141.18) | Buy |
| Bollinger Bands (100): | (130.78 - 144.54) | Buy |
CTXR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.52 | Buy |
| 20-day SMA: | 0.55 | Sell |
| 50-day SMA: | 0.71 | Sell |
| 200-day SMA: | 0.72 | Sell |
| 8-day EMA: | 0.53 | Buy |
| 20-day EMA: | 0.56 | Sell |
| 50-day EMA: | 0.63 | Sell |
| 200-day EMA: | 0.73 | Sell |
A Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 138.51 | Buy |
| 20-day SMA: | 139.4 | Buy |
| 50-day SMA: | 137.48 | Buy |
| 200-day SMA: | 137.42 | Buy |
| 8-day EMA: | 139.14 | Buy |
| 20-day EMA: | 138.84 | Buy |
| 50-day EMA: | 137.92 | Buy |
| 200-day EMA: | 135.51 | Buy |
Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.10 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Agilent Technologies Earnings Growth & A Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.17 per share, and an increase next year of $0.44 per share.
Citius Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agilent Technologies Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||